32 related news articles for Nucleic Acids and Innate Immunity

The frontline of defences against viruses and other pathogens will be fortified by the creation of a new Centre of Research Excellence for Nucleic Acid Sensing, located at Hudson Institute. …  Read more

Hudson Institute of Medical Research has been recognised as a leader in RNA based medicine, with new federal government funding set to accelerate the search for new and better treatments.…  Read more

A cancer drug could play an important role in limiting the damaging effects of lung disease inflammation in COVID-19 patients, thanks to new research at Hudson Institute.…  Read more

Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.…  Read more

The COVID-19 pandemic made RNA a topic of everyday discussion – suddenly, it was everywhere. For many Hudson Institute scientists, that meant an unprecedented level of interest in something they had spent many years studying. …  Read more

Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.…  Read more

When he was 11 years old, Associate Professor Michael Gantier had a close shave with death. Failing to recover after having his appendix removed, he was rushed to emergency surgery where doctors discovered he had sepsis.…  Read more

A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.…  Read more

Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

On 16 March we were delighted to welcome a group from Fire Rescue Victoria, who are generously supporting our research into the BRCA1 or BRCA2 mutations via the Firefighters Charity Fund. …  Read more

An international study that found a novel genetic cause of lupus owes much of its success to a single lab in Melbourne.…  Read more

It’s the essential physiological response that keeps you alive but can also kill you.…  Read more

RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.…  Read more

RNA therapeutics comprise a rapidly expanding category of drugs that have the potential to revolutionise treatments for many diseases, including those currently deemed undruggable.…  Read more

In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,…  Read more

Inflammation is at the core of life-threatening severe COVID-19 cases. More than 100 researchers at Hudson Institute investigate…  Read more

The first clinical trial of a potential COVID-19 treatment involving a discovery by Hudson Institute researchers received approval in September.…  Read more

Problems and potential solutions have been identified with new gene targeting medicines that could change the way they are made to help patients.…  Read more

My name is Michael Gantier and I am a scientist at Hudson Institute. My lab is working on a potential treatment for life-threatening COVID-19 symptoms, …  Read more

Sepsis is a hyper-acute inflammatory response leading to life-threatening organ dysfunction. Sepsis is usually caused by bacterial infections; however, the COVID-19 pandemic illustrates that hyper-acute inflammation can also be part of viral infections.…  Read more

Biotech company Noxopharm is seeking approval from the US FDA for a clinical trial in COVID-19 patients of an end-stage prostate cancer drug, following a discovery by Hudson Institute researchers that it could act as an anti-inflammatory.…  Read more

An existing cancer drug could potentially modify a severe hyper-inflammatory ‘storm’ associated with some conditions, which may include the COVID-19 virus, according to Hudson Institute researchers.…  Read more

Hudson Institute scientists have discovered how a molecule is transferred between damaged cells and healthy immune cells, which might cause toxic inflammation in a host of diseases.…  Read more

More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

Hudson Institute’s finest medical researchers will continue to push the boundaries in their field thanks to continued generous support from Mr Peter Fielding and the Fielding Foundation. This year, Research Group Heads, Associate Professor Claudia Nold (2019 Fielding Foundation Fellowship) and Dr Michael Gantier (2019 Fielding Innovation Award), were rewarded for their innovative scientific projects.…  Read more

Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts. It was all part of the Next Big Idea Award on August 30, which aims to encourage, reward and facilitate commercially focused innovation among our PhD…  Read more

A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.…  Read more

Scientists from across the world discussing immunology research…  Read more

The Australian Research Council has awarded leading scientist and biological engineer, Dr Michael Gantier, a 2014 Future Fellowship for his outstanding research at the MIMR-PHI Institute.…  Read more